NIH-funded research NIH-funded research

Investigating how immune responses in the body and brain affect cognitive decline in aging and Alzheimer's disease

Official title: The role of peripheral versus brain myeloid immunity in the cognitive decline of aging and Alzheimer's disease

Funded at Stanford University · NIH-10524957 · Data updated 2026-11-12

This study is looking at how immune cells in the brain and body affect memory and thinking problems that come with aging and Alzheimer's disease, and it’s for older adults who want to understand more about what might help keep their minds sharp.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startAugust 15, 2022
Project endJuly 31, 2025
Funding year2022
Award (this year)$1,749,426
NIH project number1RF1AG079131-01
Project IDNIH-10524957 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing cognitive decline or those at risk for Alzheimer's disease.

Less likely to help

Patients with cognitive decline due to non-aging related factors may not benefit from this research.

What this research studies

This research explores the impact of immune responses from both the brain and the peripheral body on cognitive decline associated with aging and Alzheimer's disease. It aims to understand how changes in immune cells outside the brain, known as peripheral myeloid cells, contribute to cognitive issues, alongside the role of brain-specific immune cells called microglia. By using innovative techniques, the study will compare the effects of these two immune systems on cognitive health in aging and Alzheimer's models. This could lead to new insights into how to prevent or treat cognitive decline in older adults.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cognitive decline in aging and Alzheimer's disease.

How similar studies have gone: Previous research has shown promising results in understanding the role of immune responses in cognitive decline, but this specific approach is relatively novel.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Andreasson, Katrin I. — Stanford University
  • Study coordinator: Andreasson, Katrin I.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.